ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 20 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,219,000 | – | 2,403,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 20,075,000 | $25,225,000 | 0.77% |
| Redmile Group, LLC | 19,000,000 | $23,717,000 | 0.73% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 9,000,000 | $11,313,000 | 0.68% |
| CSS LLC/IL | 6,835,000 | $8,512,000 | 0.36% |
| Verition Fund Management LLC | 5,880,000 | $7,436,000 | 0.27% |
| Graham Capital Management, L.P. | 10,000,000 | $12,604,000 | 0.26% |
| SG Americas Securities, LLC | 120,000 | $15,175,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,000,000 | $6,235,000 | 0.07% |
| Nicholas Investment Partners, LP | 500,000 | $631,000 | 0.05% |
| DEUTSCHE BANK AG\ | 31,370,000 | $39,590,000 | 0.01% |